InfectivologyNews.net

Infectivology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

The medium-term effects of Coronavirus disease ( COVID-19 ) on multiple organ health, exercise capacity, cognition, quality of life and mental health are poorly understood. Fifty-eight COVID-19 pa ...


In the absence of effective vaccines and with limited therapeutic options, convalescent plasma is being collected across the globe for potential transfusion to coronavirus disease 2019 ( COVID-19 ) pa ...


Concerns over the safety of non-steroidal anti-inflammatory drug ( NSAID ) use during severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection have been raised. Researchers have stud ...


Prolonged symptom duration and disability are common in adults hospitalized with severe coronavirus disease 2019 ( COVID-19 ). Characterizing return to baseline health among outpatients with milder ...


Initial preliminary findings from the Papa Giovanni XXIII Hospital sponsored SISCO ( Siltuximab In Serious COVID-19 ) Study, based on a pre-planned data analysis on 24 March 2020, were presented. S ...


The results of a study has shown that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug Pembrolizumab ( Keytruda ). The ...


Data from clinical studies confirm the efficacy of switching to Dolutegravir ( DTG ) plus Rilpivirine ( RPV ) ( Juluca ) in selected patients. The primary objective of the study was to report the 9 ...


The FDA ( U.S. Food and Drug Administration ) has approved Biktarvy ( Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg, BIC/FTC/TAF ), a once-daily single tablet regimen ( STR ) for ...


In a letter published in the cancer journal Annals of Oncology, researchers led by Jean-Philippe Spano, at Pitie-Salpetriere Hospital AP-HP in Paris, France, have reported that while treating an HIV-i ...


A major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women’s Hospital ( BWH ) has shown that a novel agent can protect against the most common viral infection that ...


Fungal infections that are resistant to treatment are an emerging public health problem, but everyone has a role in preventing these infections and reducing antifungal resistance. Just like antibio ...


A single subcutaneous injection of Canakinumab, a monoclonal antibody to the inflammation driver IL-1 beta, lowered inflammation in arteries of 10 people taking suppressive antiretroviral therapy ( AR ...


The FDA ( Food and Drug Administration ) has approved Genvoya ( Elvitegravir 150 mg / Cobicistat 150 mg / Emtricitabine 200 mg / Tenofovir alafenamide 10 mg or E/C/F/TAF ) for the treatment of HIV-1 i ...


The first detailed results from phase 3 clinical trials of its lead drug candidate, Eravacycline, in development to treat complicated intra-abdominal infections ( cIAI ) and complicated urinary tract ...


Clinical effectiveness of previous regimens to treat Plasmodium vivax infection have been hampered by compliance. A study has assessed the dose-response, safety, and tolerability of single-dose Tafeno ...